v3.26.1
Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Mar. 31, 2024 $ 1 $ 77,463 $ (65,929) $ 11,535
Balance (in Shares) at Mar. 31, 2024 1,082      
Issuance of common stock and warrants in private placement, net $ 1 11,366 11,367
Issuance of common stock and warrants in private placement, net (in Shares) 434      
Issuance of common stock and warrants in public offering, net 7,344 7,344
Issuance of common stock and warrants in public offering, net (in Shares) 182      
At-the-market sales of stock, net 2,114 2,114
At-the-market sales of stock, net (in Shares) 31      
Exercise of warrants 1,109 1,109
Exercise of warrants (in Shares) 57      
Shares issued for services 51 51
Shares issued for services (in Shares) 1      
Issuances under equity incentive plan 24 24
Issuances under equity incentive plan (in Shares) 3      
Stock-based compensation 2,357 2,357
Net loss (18,824) (18,824)
Balance at Mar. 31, 2025 $ 2 101,828 (84,753) 17,077
Balance (in Shares) at Mar. 31, 2025 1,790      
Issuance of common stock upon public offering, net $ 3 13,635 13,638
Issuance of common stock upon public offering, net (in Shares) 2,536      
Issuance of common stock and warrants from warrant inducement offering, net 3,947 3,947
Issuance of common stock and warrants from warrant inducement offering, net (in Shares) 217      
At-the-market sales of stock, net 1,882 1,882
At-the-market sales of stock, net (in Shares) 96      
Exercise of warrants 5 5
Exercise of warrants (in Shares) 18      
Shares issued for services 11 11
Shares issued for services (in Shares)      
Issuances under equity incentive plan 12 12
Issuances under equity incentive plan (in Shares) 4      
Reclassification of liability-classified warrants to equity 2,864 2,864
Stock-based compensation 1,765 1,765
Net loss (28,242) (28,242)
Balance at Mar. 31, 2026 $ 5 $ 125,949 $ (112,995) $ 12,959
Balance (in Shares) at Mar. 31, 2026 4,661